AAREY DRUGS & PHARMACEUTICALS (AAREYDRUGS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 158.18 50.96 57.83 76.48 210.35 126.91 105.14 133.79 108.10 102.21 84.16 96.43
YOY Revenue Growth % 31.55% -56.57% -24.17% 22.42% 32.98% 149.06% 81.81% 74.94% -48.61% -19.47% -19.96% -27.93%
Other Income 5.54 0.70 0.84 0.29 5.14 1.58 0.02 0.68 7.54 1.55 0.79 4.18
Total Income 163.72 51.65 58.67 76.77 215.49 128.49 105.16 134.47 115.64 103.76 84.95 100.61
Total Expenses + 167.23 44.98 54.18 78.32 219.55 117.23 105.08 132.66 114.01 102.03 83.47 99.68
Cost of Materials Consumed 164.67 43.37 53.36 77.22 213.81 115.09 102.56 131.46 123.75 93.07 78.89 99.30
Employee Benefit Expense 0.29 0.13 0.09 0.20 0.30 0.14 0.22 0.18 0.27 0.14 0.19 0.15
Other Expenses 2.27 1.48 0.72 0.91 5.44 2.00 2.30 1.02 3.51 2.53 0.85 1.00
Operating Profit -9.05 5.98 3.65 -1.84 -9.20 9.68 0.06 1.13 -5.91 0.18 0.69 -3.26
OPM % -5.7% 11.7% 6.3% -2.4% -4.4% 7.6% 0.1% 0.8% -5.5% 0.2% 0.8% -3.4%
Profit Before Tax + 2.64 0.72 1.01 1.47 2.15 1.33 1.75 1.40 1.63 1.73 1.48 0.92
Tax Expense 1.29 0.00 0.22 0.44 -0.01 0.09 0.15 0.68 1.15 0.36 0.46 -0.35
Tax % 48.7% 0% 22.1% 30.2% -0.3% 6.9% 8.6% 48.7% 71.1% 20.6% 30.9% -38.3%
Profit After Tax 1.35 0.72 0.78 1.02 2.15 1.24 1.60 0.72 0.47 1.37 1.02 1.28
EPS (Basic) 0.14 0.29 0.31 0.40 0.77 0.88 1.14 0.26 0.04 0.48 0.72 0.20

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 473.94 395.62 62.47 492.68
YOY Revenue Growth % 19.8% 533.28% -87.32% -
Other Income 9.81 6.96 0.48 2.75
Total Income 483.76 402.58 62.95 495.43
Total Expenses + 477.65 397.02 62.39 14.12
Cost of Materials Consumed 472.87 387.76 60.07 0.00
Employee Benefit Expense 0.81 0.72 0.18 4.78
Other Expenses 8.83 8.55 2.14 9.35
Operating Profit -3.71 -1.41 0.09 478.56
OPM % -0.8% -0.4% 0.1% 97.1%
Profit Before Exceptional 6.10 5.34 0.75 10.03
Exceptional Items 0.00 0.00 0.00 0.00
Profit Before Tax + 6.10 5.34 0.75 10.03
Tax Expense 2.08 0.66 0.25 2.50
Tax % 34.1% 12.3% 33.7% 24.9%
Profit After Tax 4.02 4.68 0.49 7.53
EPS (Basic) 3.27 1.84 0.19 2.72

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 24.98 206.87 20.72 0.00
Property, Plant & Equipment 16.22 14.66 13.94 0.00
Capital Work in Progress 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00
Current Assets + 213.28 98.12 270.61 0.00
Inventories 45.48 34.68 28.82 0.00
Trade Receivables 129.61 0.00 189.78 0.00
Cash and Cash Equivalents 1.47 1.59 0.71 0.00
Current Investments 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00
Equity Share Capital 28.05 28.05 25.38 0.00
Other Equity 110.43 104.72 92.03 0.00
Non-Current Liabilities 2.91 3.97 5.78 0.00
Current Liabilities 96.88 168.24 168.13 0.00
Total Liabilities 99.79 172.22 173.91 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 9.65 7.89 -39.09 18.59
Cash from Investing Activities -5.94 -7.32 11.15 24.38
Cash from Financing Activities -3.83 4.10 -22.54 4.38
Net Increase/Decrease in Cash -0.12 4.68 -50.48 46.89